|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date / Period | Status |
|---|---|---|
| Emphysematous bronchitis | 21-Apr-2014 | active |
| Chronic sinusitis | 10-Jan-2008 | active |
| Anemia | 25-Jun-2007 | active |
| COVID-19 | 18-Oct-2020 - 07-Nov-2020 | inactive |
| Sinusitis | 04-Nov-2019 - 13-Feb-2020 | inactive |
| Viral sinusitis | 26-Nov-2018 - 03-Dec-2018 | inactive |
| Acute viral pharyngitis | 05-Apr-2017 - 16-Apr-2017 | inactive |
Medication list
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| 60 ACTUAT Fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler | 2025-06-09 | - | 1 inhalation (0.25 mg/0.05 mg) twice daily | Chronic obstructive bronchitis (disorder) |
| Albuterol (as albuterol sulfate) 5 mg/mL solution for inhalation | 2025-06-09 | - | 2.5 mg (0.5 mL of 5 mg/mL solution) via nebulizer every 4 to 6 hours as needed | Chronic obstructive bronchitis (disorder) |
| Ferrous sulfate 325 mg prolonged-release oral tablet | 2007-07-02 | - | 1 tablet (325 mg) by mouth once daily | - |
Immunizations list
| Vaccine | Date |
|---|---|
| Influenza virus antigen only vaccine product | 09-Jun-2025 |
| SARS-CoV-2 mRNA vaccine | 15-Feb-2021 |
| Hepatitis A virus antigen only vaccine product | 24-Apr-2017 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 24-Apr-2017 |
Procedure History list
| No known procedures |
Allergies and Intolerances
| No known allergies or intolerances |
Care Plan
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Chronic obstructive pulmonary disease clinical management plan | 21-Apr-2014 | Chronic obstructive bronchitis (disorder) |
|
||
| Diabetes self management plan | 25-Jun-2007 | Prediabetes (finding) |
|
Vital Signs
| Vital Signs | 2025-06-09 | 2024-06-03 |
|---|---|---|
| Body Height | 178.8 cm | 178.8 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 {score} | 1 {score} |
| Body Weight | 96.1 kg | 96.1 kg |
| Body mass index (BMI) [Ratio] | 30.1 kg/m2 | 30.1 kg/m2 |
| Heart rate | 86 /min | 67 /min |
| Respiratory rate | 14 /min | 14 /min |
| Blood pressure panel with all children optional | 85 mm[Hg] | 86 mm[Hg] |
Relevant diagnostic tests/laboratory data
| Recent Lab Observations | 09-JUN-2025 | Reference Range | Unit |
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 6.4 H | 4.0 - 5.6 | % |
| Glucose [Mass/volume] in Blood | 88.0 | 70 - 100 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 10.6 | 7 - 18 | mg/dL |
| Creatinine [Mass/volume] in Blood | 1.2 | 0.6 - 1.3 | mg/dL |
| Calcium [Mass/volume] in Blood | 9.0 | 8.5 - 10.5 | mg/dL |
| Sodium [Moles/volume] in Blood | 138.1 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 4.7 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Blood | 110.2 H | 98 - 107 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 26.7 | 22 - 29 | mmol/L |
Device Use
| Device | Date (since) |
|---|---|
| Portable oxygen cylinder (physical object) | 11-May-2020 |
| Oxygen concentrator (physical object) | 11-May-2020 |
| Home nebulizer (physical object) | 18-Apr-2016 |
| Blood glucose meter (physical object) | 25-Jun-2007 |